Sanofi Already Decided to Close Insulin City. A Subsidy Is All That Changed
Sanofi, the French pharmaceutical giant, weighed closing its Frankfurt insulin plant and moving production to France. On September 8 the European Commission approved €400 million in German state aid to keep it where it is.